Cumulative metabolic burden and urinary albumin-to-creatinine ratio in non-diabetic adults: a nationwide population-based study.

Urinary Albumin-to-Creatinine Ratio and Risk of Incident Cardiovascular Disease in the KoGES-ARIRANG Community-Based Cohort

Low-grade albuminuria may serve as an early biomarker of cardiovascular risk in otherwise healthy individuals, particularly in subgroups susceptible to hormonal or metabolic changes, and may be a practical tool for early risk stratification and prevention of CVD.

Urine Albumin-to-Creatinine Ratio Reveals Kidney Disease Improving Global Outcomes Risk Reclassification in Cardiovascular-Kidney-Metabolic-Era Community Screening.

Association of Metabolic Syndrome with Early Renal Dysfunction in Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cross-Sectional Study

Objective: To determine the association between metabolic syndrome and early renal dysfunction among patients with type 2 diabetes mellitus attending a tertiary-care hospital in Pakistan. Methodology: This Cross-sectional study was conducted at Bakhtawar Amin Hospital in Multan from January 2024 to December 2025. We e...

Relationship of Glycated Hemoglobin with Urinary Albumin-Creatinine Ratio and eGFR in Patients with Type 2 Diabetes Mellitus

Poor glycemic control is strongly associated with increased albuminuria and declining renal function in patients with T2DM, and routine monitoring of HbA1c, uACR, and eGFR may facilitate early identification of diabetic kidney disease.

Insulin resistance and uric acid-related metabolic disturbances jointly identify individuals at high risk of advanced cardiovascular-kidney-metabolic syndrome: a population-based study

Higher TyG and SUA levels, particularly their co-occurrence, were associated with prevalent advanced CKM, suggesting these biomarkers may characterize distinct but overlapping metabolic profiles relevant to CKM assessment.

Incident chronic kidney disease risk and the predictive value of the uric acid-to-HDL ratio in lean and non-lean MASLD: a prospective cohort and multi-omics study.